EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Incidental Findings Identified by Prenatal Microarray Analysis and Consensus Reporting Criteria of the Catalan Public Health Network XIGENICS

Irene Mademont-Soler iD, Neus Castells-Sarret, Adela Cisneros, Laura Foj, Clara Benavent-Bofill, Mar Xunclà, Marina Viñas-Jornet iD, Andrea Ros, Natalia Rey, Ignacio Blanco, Ricard López-Ortega, María Obón und 1 weitere

Prenatal Diagnosis · 2025

DOI: 10.1002/pd.6746 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, 2025. Verfasst von Irene Mademont-Soler und 12 weiteren Autor:innen. Beteiligte Einrichtung: Àrea de Genètica Clínica i Consell Genètic, Laboratori Clínic Territorial ICS Girona, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain. Hauptthemen laut MEDLINE: Incidental Findings, Microarray Analysis, Prenatal Diagnosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The study aimed to evaluate the frequency of pathogenic copy number variants (CNVs) classified as incidental findings (IFs) in prenatal diagnosis and to develop consensus recommendations for standardizing their reporting across six centers within the Catalan public health system (XIGENICS network).

Method

A retrospective review of 4219 consecutive prenatal microarrays performed within the network from 2018 to 2023 was conducted, including all referral reasons. To develop consensus recommendations, several discussion meetings were held along with an extensive review of the existing literature.

Results

A total of 69 IFs were identified in 68 samples, revealing a detection rate of 1.6%. They included: 5 CNVs associated with neurodevelopmental disorders and/or congenital defects with complete penetrance, 41 CNVs for neurodevelopmental disorders and/or congenital defects with incomplete penetrance, 4 disorders that can potentially be prevented or treated, 5 non‐childhood onset neurological disorders, 13 X‐linked disorders (mainly STS and DMD deletions), and 1 deletion of the SHOX gene. Long‐term follow‐up revealed that newborns with high penetrance neurosusceptibility CNVs exhibited clinical manifestations more frequently than those with low penetrance CNVs. At the time of reporting, 52 IFs were disclosed, while 17 were not. According to the new consensus criteria, 43 IFs would now be reported, 17 would not, and 9 would depend on parental decision. CNVs consistent with the referral reason were identified in 4% of cases.

Conclusion

This study represents the largest series rigorously documenting all identified IFs in consecutive pregnancies evaluated by microarray, including both reported and unreported findings. IFs were found at a higher frequency than previously recognized, underscoring the need for specific clinical attention. Comprehensive consensus reporting recommendations were developed to ensure uniformity of criteria, and an ad hoc committee was established to manage complex cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Incidental FindingsMicroarray AnalysisPrenatal DiagnosisAdultFemaleHumansPregnancyDNA Copy Number VariationsPublic HealthRetrospective StudiesSpain

Autor:innen und Institutionen

  • Àrea de Genètica Clínica i Consell Genètic, Laboratori Clínic Territorial ICS Girona, Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain.
  • Grup de Trastorns del Neurodesenvolupament, Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta, Girona, Spain.
  • Àrea de Genètica Clínica i Molecular, Hospital Universitari Vall d'Hebron, Institut Català de la Salut, Barcelona, Spain.
  • Grup de Medicina Genètica, Vall d'Hebron Institut de Recerca, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Servei Hematologia Laboratori, Laboratori Clínic Territorial ICS Metropolitana Nord, ICO-Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Unitat de Citogenètica i Genètica Mèdica, Laboratori Clínic Territorial ICS Lleida, Hospital Universitari Arnau de Vilanova, Lleida, Spain.

ORCID-Profile: Irene Mademont-Soler, Marina Viñas-Jornet

Zitieren

APA

Mademont-Soler, I., Castells-Sarret, N., Cisneros, A., Foj, L., Benavent-Bofill, C., Xunclà, M., Viñas-Jornet, M., Ros, A., Rey, N., Blanco, I., López-Ortega, R., Obón, M., & Plaja, A. (2025). Incidental Findings Identified by Prenatal Microarray Analysis and Consensus Reporting Criteria of the Catalan Public Health Network XIGENICS. Prenatal Diagnosis. https://doi.org/10.1002/pd.6746

Vancouver

Mademont-Soler I, Castells-Sarret N, Cisneros A, Foj L, Benavent-Bofill C, Xunclà M, et al. Incidental Findings Identified by Prenatal Microarray Analysis and Consensus Reporting Criteria of the Catalan Public Health Network XIGENICS. Prenatal Diagnosis. 2025. doi:10.1002/pd.6746

BibTeX
@article{MademontSoler2025,
  author = {Mademont-Soler, Irene and Castells-Sarret, Neus and Cisneros, Adela and Foj, Laura and Benavent-Bofill, Clara and Xunclà, Mar and Viñas-Jornet, Marina and Ros, Andrea and Rey, Natalia and Blanco, Ignacio and López-Ortega, Ricard and Obón, María and Plaja, Alberto},
  title = {Incidental Findings Identified by Prenatal Microarray Analysis and Consensus Reporting Criteria of the Catalan Public Health Network XIGENICS},
  journal = {Prenatal Diagnosis},
  year = {2025},
  doi = {10.1002/pd.6746}
}
Kostenlos starten →